At EVERSANA, we take pride in being recognized as a Great Place to Work globally. Our vision is clear: to create a healthier world through innovative commercialization services tailored for the life sciences industry. With a team of over 7,000 dedicated employees, we are committed to supporting more than 650 clients, ranging from cutting-edge biotech start-ups to established pharmaceutical companies. Together, we strive to make a significant impact every day on the lives of patients who depend on innovative therapies.

We believe that diversity in backgrounds and experiences strengthens our organization. Our priority is improving patient lives worldwide, and we seek individuals from every walk of life to join us in shaping the future of healthcare and life sciences. If you share our values and care about our patients, clients, and each other, we welcome you to join our mission at EVERSANA.

Position Overview:
The Medical Science Liaison/Senior Medical Science Liaison in Hematology/Oncology serves as a knowledgeable, field-based expert on Cutaneous T Cell Lymphoma (CTCL). This role is essential in fostering scientific discussions with healthcare professionals and leaders about clinical practices, value in care, and research-oriented peer-to-peer scientific exchanges involving CTCL and our products, including Lymphir, a novel recombinant cytotoxic fusion protein. You will engage meaningfully with Key Opinion Leaders (KOLs), healthcare practitioners (HCPs), and professional societies to build collaborative scientific relationships across the hematology and oncology community.

Key Responsibilities:

• Act as the primary field contact for Medical Deployment in your territory.
• Maintain up-to-date scientific and clinical expertise related to oncology, particularly in CTCL standards of care.
• Develop and execute KOL engagement plans to cultivate long-term relationships with key stakeholders.
• Engage in meaningful scientific exchanges with the medical community and participate in advisory boards.
• Manage ongoing territory development, including KOL tracking and clinical program requests.
• Collaborate with research teams supporting clinical trial sites and investigators.
• Conduct profiling efforts for KOLs and significant accounts to understand patient care pathways.
• Work alongside commercial teams to ensure an integrated approach to account engagement.
• Provide critical insights to internal teams based on interactions with KOLs.
• Represent EVERSANA at medical conferences and meetings, ensuring thorough documentation of insights gained.
• Adhere to compliance regulations and corporate SOPs in all interactions and documentation.
• Support internal training initiatives as needed and engage in other duties as required.

Qualifications:

• An advanced degree (e.g., PharmD, PhD, MD, MSN, or NP/PA) is strongly preferred.
• For MSL position: Minimum of 2 years of MSL experience, including at least 1 year in Oncology. For Senior MSL position: Minimum of 5 years in Pharma with 3 years in oncology; hematology/oncology experience is strongly preferred.
• Prior product launch experience is essential.
• Strong scientific, clinical, and business acumen, with impressive communication skills.
• Ability to interpret and present scientific data to engage KOLs effectively.
• Desirable knowledge of NCCN guidelines and payer systems.
• Familiarity with NCI Cooperative Groups and Oncology Research Consortiums.
• Proficiency in presenting to formulary and P&T committees.
• Strong understanding of institutions and clinics involved in treating oncology-related conditions.
• Excellent written and oral presentation skills.
• Willingness to travel frequently (approximately 70%) for KOL meetings, site visits, and conferences.

Commitment to Diversity and Inclusion:
EVERSANA champions Diversity, Equity, and Inclusion as fundamental components of our success. We welcome applicants from various backgrounds, and our inclusive culture thrives on diverse perspectives. We are an Equal Opportunity Employer, and all voices contribute to improving the lives of patients through healthcare innovation.